Key Record Dates
ClinicalTrials.gov Identifier: | NCT04833894 |
---|---|
Brief Title: | Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis |
First Submitted : | March 16, 2021 |
First Submitted that Met QC Criteria : | April 2, 2021 |
First Posted : | April 6, 2021 |
Last Update Submitted that Met QC Criteria : | May 2, 2023 |
Last Update Posted : | May 3, 2023 |